rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Morningside Venture Investments Ltd

10% owner

Company insider

Files Form 4 as: 10% owner, Apnimed; 10% owner, Amylyx Pharmaceuticals; 10% owner, Kezar Life Sciences; 10% owner, GreenLight Biosciences Holdings, PBC; 10% owner, Apellis Pharmaceuticals; 10% owner, Liquidia Technologies.

Every Form 4 they filed

In numbers

Trades disclosed
101
Buys
15
Sells
30
Bought
$90.3M
Sold
$26.4M
Companies
6
Companies where not an officer
6
First trade
13 Nov 2017
Last trade
3 Aug 2026
Last filed
5 Aug 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
APMD Apnimed10% owner · Biotechnology · last 3 Aug 20261 buy · 0 sells
Kezar Life Sciences10% owner · last 15 Aug 20232 buys · 19 sells
AMLX Amylyx Pharmaceuticals10% owner · Biotechnology · last 15 Aug 20231 buy · 11 sells
GreenLight Biosciences Holdings, PBC10% owner · last 24 Jul 20232 buys · 0 sells
Apellis Pharmaceuticals10% owner · last 18 Nov 20219 buys · 0 sells
Liquidia Technologies10% owner · last 30 Jul 20180 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code C—6,840,213filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—6,840,213filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—6,840,213filing
3 Aug 2026filed 5 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code C—9,227,454 at $0.00filing
3 Aug 2026filed 5 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code C—1,088,986.3 at $0.00filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Bought$5.0M312,500 at $16.00filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code C$1.1M75,624 at $14.40filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—75,624filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—75,624filing
3 Aug 2026filed 5 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code C—9,227,454 at $0.00filing
3 Aug 2026filed 5 Aug 2026APMD Apnimedoption or derivative · BiotechnologySEC FORM 4 Code C—1,088,986.3 at $0.00filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code C—6,840,213filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—6,840,213filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—6,840,213filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Bought$5.0M312,500 at $16.00filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code C$1.1M75,624 at $14.40filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—75,624filing
3 Aug 2026filed 5 Aug 2026APMD ApnimedBiotechnologySEC FORM 4 Code J—75,624filing
15 Aug 2023filed 17 Aug 2023AMLX Amylyx PharmaceuticalsBiotechnologySEC FORM 4 Code G—2,000,000 at $0.00filing
15 Aug 2023filed 17 Aug 2023Kezar Life SciencesSEC FORM 4 Code G—3,500,000 at $0.00filing

News

Apnimed to Present Five Abstracts, Including Two Late-Breakers at CHEST 2026APMD · manilatimes.net · 12 Oct 2026

0 headlines in the last 90 days name Morningside Venture Investments Ltd; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.

Sectors

Health Care13
Not placed32

Buys in green, sells in red, by the company’s sector.

Related people

Alpha Wave Ventures GP, Ltd10% owner · 10% owner at Apnimed, filing Form 4 there in the last year
Lawrence G. MillerDirector · Director at Apnimed, filing Form 4 there in the last year
Gary SenderDirector · Director at Apnimed, filing Form 4 there in the last year
Kevin Robert LindDirector · Chief Executive Officer at Apnimed, filing Form 4 there in the last year
Paul R. FonteyneDirector · Director at Apnimed, filing Form 4 there in the last year
George M. Milne Jr.Director · Also traded AMLX in the last 90 days
Camille L. BedrosianChief Medical Officer · Also traded AMLX in the last 90 days
Gina MazzarielloChief Legal Officer · Also traded AMLX in the last 90 days